Crystals (Jul 2022)

Towards the Development of Novel Diclofenac Multicomponent Pharmaceutical Solids

  • Francisco Javier Acebedo-Martínez,
  • Carolina Alarcón-Payer,
  • Helena María Barrales-Ruiz,
  • Juan Niclós-Gutiérrez,
  • Alicia Domínguez-Martín,
  • Duane Choquesillo-Lazarte

DOI
https://doi.org/10.3390/cryst12081038
Journal volume & issue
Vol. 12, no. 8
p. 1038

Abstract

Read online

Multicomponent pharmaceutical materials offer new opportunities to address drug physicochemical issues and to obtain improved drug formulation, especially on oral administration drugs. This work reports three new multicomponent pharmaceutical crystals of the non-steroidal anti-inflammatory drug diclofenac and the nucleobases adenine, cytosine, and isocytosine. They have been synthesized by mechanochemical methods and been characterized in-depth in solid-state by powder and single crystal X-ray diffraction, as well as other techniques such as thermal analyses and infrared spectroscopy. Stability and solubility tests were also performed on these materials. This work aimed to evaluate the physicochemical properties of these solid forms, which revealed thermal stability improvement. Dissociation of the new phases was observed in water, though. This fact is consistent with the reported observed layered structures and BFDH morphology calculations.

Keywords